Bibliografia

1. Arranz MJ, Gonzalez-Rodriguez A, Perez-Blanco J, Penadés R, Gutierrez B, Ibañez L, Arias B, Brunet M, Cervilla J, Salazar J, Catalan R. A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments. Transl Psychiatry. 2019 Jul 25;9(1):177. doi: 10.1038/s41398-019-0511-9. PMID: 31346157; PMCID: PMC6658489.

2. Pirmohamed M. Pharmacogenomics: current status and future perspectives. Nat Rev Genet. 2023 Jun;24(6):350-362. doi: 10.1038/s41576-022-00572-8. Epub 2023 Jan 27. PMID: 36707729.

3. Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X, Huai C, Shen L, Zhang N, He L, Qin S. Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int J Mol Sci. 2021 Nov 26;22(23):12808. doi: 10.3390/ijms222312808. PMID: 34884615; PMCID: PMC8657965.

4. Hernandez M, Cullell N, Cendros M, Serra-Llovich A, Arranz MJ. Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments. Pharmaceutics. 2024 Feb 7;16(2):244. doi: 10.3390/pharmaceutics16020244. PMID: 38399298; PMCID: PMC10893329.

5. Morris SA, Alsaidi AT, Verbyla A, Cruz A, Macfarlane C, Bauer J, Patel JN. Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review. Clin Pharmacol Ther. 2022 Dec;112(6):1318-1328. doi: 10.1002/cpt.2754. Epub 2022 Oct 9. PMID: 36149409; PMCID: PMC9828439.

6. Arranz MJ, Salazar J, Bote V, Artigas-Baleri A, Serra-Llovich A, Triviño E, Roige J, Lombardia C, Cancino M, Hernandez M, Cendros M, Duran-Tauleria E, Maraver N, Hervas A. Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics. 2022 May 6;14(5):999. doi: 10.3390/pharmaceutics14050999. PMID: 35631585; PMCID: PMC9143818.

7. Cullell N, Carrera C, Muiño E, Torres N, Krupinski J, Fernandez-Cadenas I. Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants. Oncotarget. 2018 Jun 26;9(49):29238-29258. doi: 10.18632/oncotarget.25579. PMID: 30018749; PMCID: PMC6044386.

8. Cullell N, Carrera C, Muiño E, Torres-Aguila NP, Cárcel-Márquez J, González-Sánchez J, Gallego-Fabrega C, Molina J, Besora S, Sotoca J, Buongiorno MT, Jiménez-Conde J, Giralt-Steinhauer E, de Torres-Chacón R, Montaner J, Mancha F, Cabezas JA, Martí-Fàbregas J, Prats-Sánchez L, Camps-Renom P, Purroy F, Cambray S, Freijo MDM, Vives-Bauzá C, Tur S, Font MÀ, López-Cancio E, Hernandez-Perez M, Obach V, Calleja A, Arenillas J, Rodríguez-Yáñez M, Castillo J, Sobrino T, Fernández-Cádenas I, Krupinski J. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain. Sci Rep. 2020 Feb 18;10(1):2806. doi: 10.1038/s41598-020-59641-9. PMID: 32071341; PMCID: PMC7028945.